Okechukwu Nwoko, MD
Hand Surgery · Raleigh, NCNPI 1649435645
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,906 of the $5,196 with a category attached, or 75.2%. 16 manufacturers reported payments, led by Anika Therapeutics, Inc. at 29.1% of the total.
Across 30 payments — averaging $173.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$2K
- Smith+Nephew$1K
- Stryker$958
- Tricoast Surgical Solutions LLC$605
- Arthrex$268
- Southtech Orthopedics$175
- plus $574 from 10 others
What the payments were for
- Travel & lodging$3,90675%
- Food & beverage$1,11621%
- Education$1753%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 2 | $1,513 |
| Smith+Nephew | 6 | $1,104 |
| Stryker | 6 | $958 |
| Tricoast Surgical Solutions LLC | 1 | $605 |
| Arthrex | 2 | $268 |
| Southtech Orthopedics | 1 | $175 |
| Axogen | 3 | $118 |
| Bioventus LLC | 1 | $113 |
| Checkpoint Surgical, Inc | 1 | $99 |
| Integra Lifesciences Corporation | 1 | $90 |
| Kerecis Limited | 1 | $35 |
| Johnson & Johnson | 1 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Medartis Inc. | 1 | $21 |
| Dunamis Medical, LLC | 1 | $20 |
| Amgen | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,196 in reported general payments places this provider in the 60th percentile of 79 hand surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 28 | $158 |
| Ondansetron OdtOndansetron | 15 | $117 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $103 |
| Methylprednisolone | 19 | $95 |
| Gabapentin | 14 | $67 |
| Cyclobenzaprine Hcl | 12 | $55 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Raleigh
- Erica TaylorRaleigh$97K
- Patricia WellbornRaleigh$26K
- Ryan TarrRaleigh$19K
- Timothy LuchettiRaleigh$6K
- John EricksonRaleigh$3K
- Terry MesserRaleigh$3K
- George EdwardsRaleigh$2K
- George EdwardsRaleigh$1K
- Paul SchrickerRaleigh$1K
- James PostRaleigh$908
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.